Athos宣布其人工智能生成的全新口服G9A抑制剂ATH-063的I期临床试验顶线数据，显示其对强效抗炎调节性T细胞的选择性扩增和激活
ATH-063在所有剂量水平下显著增加了循环调节性 […]…
Canyon Network Secures $6 Million at $60M Valuation for Its Onchain AI Oracle
New York, NY – October 16 […]
Vue Protocol Raises $6 Million to Build The Layer2 for Web3 Social
New York, NY – October 16 […]
Mitsubishi Power Completes Construction of 50MW Woody Biomass-fired Power Plant in Hyuga, Miyazaki Prefecture
TOKYO, Oct 16, 2024 ̵ […]
Orders for Gas Turbines through Partner Firm in China Reaches 150 Units
TOKYO, Oct 16, 2024 ̵ […]
Amyotrophic Lateral Sclerosis Treatment “Rozebalamin(R) for Injection 25 mg” Receives The Good Design Award 2024 for Light- Proof Vial Packaging
TOKYO, Oct 16, 2024 ̵ […]
Kincora Announces Strategic Investment & Expanded Partnership with Fleet Space
Kincora to raise A$1.27 m […]
Fujitsu to combat fake news in collaboration with leading Japanese organizations
TOKYO, Oct 16, 2024 ̵ […]
Fosun Secures EUR670 Million for Completion of Ageas Sale
HONG KONG, Oct 16, 2024 & […]